Sandra Gurrola - Jun 21, 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
Sr. VP of Finance
Signature
/s/ Sandra Gurrola
Stock symbol
ERNA
Transactions as of
Jun 21, 2024
Transactions value $
-$349
Form type
4
Date filed
6/25/2024, 04:32 PM
Previous filing
Apr 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Options Exercise +437 +47.09% 1.37K Jun 21, 2024 Direct F1
transaction ERNA Common Stock Tax liability -$349 -180 -13.19% $1.94 1.19K Jun 21, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Restricted Stock Units Options Exercise $0 -437 -50% $0.00 437 Jun 21, 2024 Common Stock 437 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit converts into one share of common stock.
F2 On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.